Search
The transition of Value Research Online has been postponed to take care of some user concerns.
You are welcome to try out the new site at https://beta.valueresearchonline.com

Glenmark Pharmaceuticals

Sector: Healthcare | Industry: Drugs & Pharma
R 282.05 7.25  | 2.64% -56.95% 9.94 7,965.61
NSE Price: Nov 14, 15:58 Change R    |  % 1-Year Change P/E Market Cap (R Cr)
NSE Nov 14, 15:58 282.05 7.25 2.64% 275.00 274.80 3,244,792 267.25 - 284.95
BSE Nov 14, 2019 282.30 7.35 2.67% 275.00 274.95 113,713 267.30 - 284.80
Exchange & Time Last Price      Day Change Open Prev Close Volume    1-Day Range
SUBSCRIBE TO THE VALUE RESEARCH STOCK INSIGHT NEWSLETTER
6M Average Volume: 1,426,316 P/B: 1.40 NSE Code: GLENMARK
52-Week Range: R 267.25 - 705.90 Dividend Yield: 0.71% BSE Code: 532296
TTM EPS: R 28.40 Book Value: R 202.14 Face Value: R 1
Number of stocks currently recommended as 'Buy' by Value Research Stock Advisor: 37
Price Graph
  • Lupin (NSE)
  • S&P BSE Sensex


Please wait while we are fetching data...
Our equity analyst team has sifted through hundreds of companies and selected a short list of stocks that you should invest in.
This list now has 37 stocks on it. Thousands of our members are using stagnant equity markets to buy great stocks at low prices.

Membership is currently available at a 40% to 60% discount. Learn more and become a member
Performance
  YTD 1-Month 3-Month 1-Year 3-Year 5-Year 10-Year
Glenmark Pharma. -59.30 0.66 -26.59 -56.95 -31.55 -18.21 2.39
S&P BSE Mid Cap -4.91 6.06 8.93 -1.36 5.59 7.64 8.62
S&P BSE Healthcare -7.19 5.42 3.28 -9.19 -5.82 -2.73 10.83
Company's return has been calculated on basis of NSE's price.
As on Nov 14, 2019
Key Ratios
Revenue Per Share (R) Earnings Per Share (R) Return on Networth (%)


Please wait
while we are fetching data...


Please wait
while we are fetching data...


Please wait
while we are fetching data...
Annual Ratios (%)
  1-Year 3-Years 5-Years
Growth
Revenue 8.72 9.27 10.66
Net Profit 15.07 7.57 11.14
EPS 15.08 7.56 10.39
Book Value 8.57 15.53 12.51
Average
Operating Margin 18.18 19.95 19.48
Net Margin 9.18 10.04 8.61
Return on Networth 17.21 20.40 19.49
Return on Investment 16.47 17.26 16.54
Interim Growth Ratios (%)
  QoQ YoY YTD
Quarterly
Revenue -9.39 7.26 -9.39
Operating Profit -14.78 -29.17 -14.78
Net Profit -32.40 -53.10 -32.40
EPS -32.41 -53.11 -32.41
TTM
Revenue 1.59 12.54 1.59
Operating Profit -7.89 3.33 -7.89
Net Profit -13.37 13.90 -13.37
EPS -13.38 13.91 -13.38
Peer Comparison
  Market Cap
(R Cr)
Revenue
(R Cr)
Net Profit
(R Cr)
Net Margin (%) RoE (%) Price to Book Price to Earnings
Glenmark Pharma. 7,965.61 10,022.73 801.28 7.94 17.21 1.40 9.94
Lupin 33,423.15 17,689.22 318.63 1.77 4.55 2.45 106.51
Piramal Enterprises 34,972.14 14,278.56 1,708.87 11.71 4.28 1.31 16.92
Insider Trades
Date Person  Buy / Sell Transaction
Type
No of Shares Price
(R)   
Value
(R Lakhs)
Sep 27, 2019 CHERYLANN PINTO  Buy Market 3,000 333.25 10.00
Sep 27, 2019 ROBIN PINTO  Buy Market 2,000 333.25 6.67
Sep 26, 2019 ROBIN PINTO  Buy Market 2,000 346.10 6.92
Sep 25, 2019 CHERYLANN PINTO  Buy Market 5,000 345.70 17.29
Sep 20, 2019 ROBIN PINTO  Buy Market 1,000 352.50 3.53
Fund Houses invested in the stock
Fund Sep-19 Jun-19 Mar-19 Dec-18 Sep-18
HDFC Mutual Fund 3.239 2.990 2.894 2.789 2.702
DSP Mutual Fund 0.368 0.761 0.578 0.444 0.330
Kotak Mahindra Mutual Fund 0.324 0.601 0.270 0.127 0.395
SBI Mutual Fund 0.097 0.098 0.293 0.328 0.258
UTI Mutual Fund 0.089 0.089 0.035 0.032 0.056
Nippon India Mutual Fund 0.054 0.016 0.028 0.011 0.177
ICICI Prudential Mutual Fund 0.044 0.070 0.007 0.002 0.006
Invesco Mutual Fund 0.024 0.032 - - -
BOI AXA Mutual Fund 0.023 0.037 0.001 0.001 -
L&T Mutual Fund 0.006 0.026 0.030 - 0.015
Figures given above are % of equity capital
Review & Analysis
News & Announcements
Contact Information

Company: Glenmark Pharmaceuticals Ltd.

Address: B/2 Mahalaxmi Chambers, 22 Bhulabhai Desai Road, Mumbai, Maharashtra - 400026

Email: [email protected]

Website: www.glenmarkpharma.com

Registrar & Transfer Agent: Karvy Fintech Pvt Ltd.-(Karvy Computuershare Pvt Ltd.)

Address: Karvy Selenium Tower B, Plot 31-32Gachibowli,Financial District, NanakramgudaHyderabad – 500032Tel. No. 040 67161500Fax. No. 040 23001153E-mail: [email protected]: www.karvy.comToll Free No. of exclusive Call Centre:1-800-345001, Karvy Selenium Tower B, Plot 31-32, Gachibowli,Financial District, Nanakramguda | Phone: 91-040-67161500 | Fax: 91-040-23001153

Email: [email protected]

Website: www.karvy.com

Essential checks
Altman Z-Score
2.56
Piotroski F-Score
7
Modified C-Score
1
5-Years Price to Earnings
9.68
5-Years Price to Book
1.36
Earnings Yield
EBIT / Enterprise value
13.15%
PEG
Price / Earnings to growth ratio
1.63
Related Stocks
  Current Price   Chng %
Abbott India R12,043.25 +2.11%
Alkem Laboratories R2,021.25 -2.16%
Aurobindo Pharma R395.80 -8.77%
Biocon R254.70 -0.78%
Cadila Healthcare R234.25 +4.23%
Glaxosmithkline Pharma R1,601.25 -0.22%
Lupin R738.35 +1.10%
Pfizer R4,001.20 -0.05%
Piramal Enterprises R1,758.10 -2.87%
Torrent Pharmaceuticals R1,771.55 -0.05%
As on Nov 14, 15:59